Pinterest isn't exactly bringing the power to the people.
For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.
The advantage goes to P&G as the larger of the two behemoths in consumer staples has been posting stronger results of late.
The company is a total ROI story, but can it share positive returns with IPO investors?
Technical charts can provide insight into coming earnings reports, and the ascending chart for the fast-food giant is indicating it's about to produce a solid report.
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
Focus on defense, as news headlines on the Mueller Report and discussion of 'Medicare For All' make stock picking tough.
Share prices that drop by much more than justified create great buying opportunities.
This health care selloff shows the value of diversification to protect our portfolios -- and to go on the offensive and find bargains.
Despite cries that call for Medicare for All is causing declines, early readings showed creep toward Realization Day for sector.